Harvard Perinatal & Pediatric Pharmacoepidemiology
@h4p_research
Followers
381
Following
82
Media
11
Statuses
93
Strive to generate evidence on the use of medications in pregnancy & childhood using epidemiological methods. @DoPE @BrighamWomens @HarvardMed @HarvardEpi
Boston, MA
Joined February 2018
We are looking for both a research specialist and a post-doctoral fellow to join the H4P team and work on perinatal and pediatric pharmacoepidemiology projects. If you are interested, please do not hesitate to reach out to us at h4p@bwh.harvard.edu: https://t.co/RECu0mNsai.
0
0
1
Today's #KolokotronesSymposium ended with a panel discussion, moderated by Dr. Brian Bateman. A sincere thank you to everyone who joined us in person and over Zoom! Inspired by the talks and audiences' questions, we will continue our research on #CausalInference in #pregnancy!
0
0
3
Dr. Huybrechts further concluded that research on medication use in #pregnancy "is not simply a yes/no question. It is about establishing the level of risk and discussing whether it is acceptable given the benefits, (other) risks, and costs."
The last presenter of 16th #KolokotronesSymposium, Dr. Krista Huybrechts, co-director of @h4p_research, demonstrated how to conduct a study in large healthcare databases using the evaluation of buprenorphine vs. methadone in #pregnancy recently published in @NEJM as a case study.
0
1
0
The last presenter of 16th #KolokotronesSymposium, Dr. Krista Huybrechts, co-director of @h4p_research, demonstrated how to conduct a study in large healthcare databases using the evaluation of buprenorphine vs. methadone in #pregnancy recently published in @NEJM as a case study.
0
0
1
Dr. Cohen concluded his talk by emphasizing how high-quality data from large healthcare datasets can be integrated with high-quality data from registries. @WmnMentalHealth
We've heard from a great roster of speakers at the #KolokotronesSymposium hosted by @CAUSALab & @h4p_research so far. Dr. Lee S. Cohen, Professor at @harvardmed, is now presenting on "Pregnancy Registries - Risk-benefit of psychotropics." #CausalInference in #Pregnancy.
0
0
0
Dr. Rasmussen in her presentation went through the regulatory efforts over the decades aimed at the prevention of birth defects due to isotretinoin.
We had a great presentation from @skr9skr9, Professor at @HopkinsMedicine who presented on "Case series and case-control studies - Isotretinoin Teratogenicity". #KolokotronesSymposium on #CausalInference in #Pregnancy. @CAUSALab @h4p_research
0
0
0
#KolokotronesSymposium #pregnancy Dr. Leyla Sahin from @US_FDA shared her view on the regulation of treatments during pregnancy. Research using large healthcare data is taking an increasingly important role in providing real-world evidence on medication in pregnancy. @CAUSALab
0
0
0
Dr. Lyerly @annelyerly ended her presentation with a thought-provoking quote from Dr. Frances Kelsey who saved the U.S. from the thalidomide catastrophe in the 1960s, which illustrates the importance of #CausalInference research in #Pregnancy. @unc_bioethics
Next speaker is up at the #KolokotronesSymposium, #CausalInference in #Pregnancy! @annelyerly, Professor at @UniversityofNo7, is presenting on "Before Treatments are Approved: Challenges of Randomized Trials in #Pregnancy." @CAUSALab @h4p_research
0
0
0
The 16th #KolokotronesSymposium is officially underway! @CAUSALab's Prof. Sonia Hernandez-Diaz, Co-Director of @h4p_research welcomed everyone and kicked off the day with a presentation on "Why is #CausalInference harder during #pregnancy?"
0
3
21
Dr. Anne Lyerly @annelyerly from @unc_bioethics continued the introduction by highlighting the "pregnancy paradox" - challenges that we encounter in including pregnant people in randomized trials.
It's happening - the Kolokotrones Symposium on Causal Inference in Pregnancy started with Dr. Sonia Hernadez-Diaz explaining "Why is Causal Inference Harder During Pregnancy." @CAUSALab
0
0
0
It's happening - the Kolokotrones Symposium on Causal Inference in Pregnancy started with Dr. Sonia Hernadez-Diaz explaining "Why is Causal Inference Harder During Pregnancy." @CAUSALab
0
3
7
We are holding a Symposium at the Harvard TH Chan School of Public Health on 12/15 1-4pm, co-sponsored by @CAUSALab and @h4p_research . Welcome to join us by registering for free and attending in person or via Zoom!
Registration is open! The 16th #KolokotronesSymposium takes place on 12/15 both in-person at @HarvardChanSPH & virtually. Join us for a @CAUSALab & @h4p_research event to learn about #causalinference in #pregnancy. Learn more + register: https://t.co/KIgQbo8mCW
0
1
4
Check out our monthly literature scan covering perinatal and pediatric pharmacoepidemiology papers from the months of November and December 2022! https://t.co/YfkkE9tD2i
0
0
2
Observational studies are often the only option to estimate effects of interventions during #pregnancy. Thinking of emulating a #TargetTrial during pregnancy using healthcare databases? Here we review challenges and propose solutions to common biases👇 https://t.co/DwDOoU0Qcn
2
44
153
Check out the call for papers in the special series on Pediatric and Perinatal Pharmaco-epidemiology @PPE_journal. Dr. Sonia Hernandez-Diaz will be one of the guest editors for this series (Submission deadline: Saturday, 1 April 2023). https://t.co/aTC0SIScPM
0
1
3
If you are interested in joining our group, please do not hesitate to reach out!
.@h4p_research is seeking a research specialist and a post-doctoral fellow to work on perinatal & pediatric pharmacoepidemiology projects. If you're interested please reach out to Krista Huybrechts at h4p@bwh.harvard.edu. Learn more about the position:
0
0
2
New paper from our #InPreSS collaboration on antipsychotic safety in pregnancy. 🤗
Good things happen slowly…Important results from our #InPreSS collaboration. #Antipsychotic safety during #pregnancy
@h4p_research @uni_iceland @UNSWMedicine @CPHIceland @Folkehelseinst @karolinskainst
0
0
2
Congrats to @PORTAL_Research @h4p_research @CEE1983 student Liz Nyamwange for being a top 300 scholar in the @Society4Science #RegeneronSTS Regeneron Science Talent Search for her work revealing disparities in adherence to hypertensive meds in pregnancy!
societyforscience.org
$1.2 Million Awarded to Nation’s Most Promising Young Scientists and Their Schools in the Regeneron Science Talent Search 2023 WASHINGTON, D.C. (Jan. 10,
1
3
3
Check out our monthly literature scan covering perinatal and pediatric pharmacoepidemiology papers for the month of October 2022. https://t.co/YfkkE9tD2i
0
0
1
Our new publication was featured in this week's issue of @NEJM with an editorial. We attempt to address the limitations of the MOTHER trial and compared the risks of adverse neonatal and maternal outcomes between maternal buprenorphine and methadone use:
nejm.org
Opioid agonist therapy is strongly recommended for pregnant persons with opioid use disorder. Buprenorphine may be associated with more favorable neonatal and maternal outcomes than methadone, but ...
0
1
1